Azathioprine



Indications and Reactions:

Role Indications Reactions
Primary
Crohn's Disease 25.3%
Colitis Ulcerative 12.3%
Product Used For Unknown Indication 12.3%
Immunosuppression 10.2%
Drug Use For Unknown Indication 7.6%
Immunosuppressant Drug Therapy 4.6%
Renal Transplant 4.4%
Systemic Lupus Erythematosus 3.6%
Rheumatoid Arthritis 3.0%
Autoimmune Hepatitis 2.7%
Myasthenia Gravis 2.5%
Pemphigus 2.4%
Prophylaxis Against Transplant Rejection 1.8%
Colitis 1.3%
Dermatitis Atopic 1.1%
Hypertension 1.1%
Dermatomyositis 1.0%
Hepatitis C 1.0%
Pemphigoid 0.8%
Takayasu's Arteritis 0.8%
Vomiting 12.9%
Pyrexia 9.6%
Weight Decreased 9.3%
Pancytopenia 7.6%
Sepsis 5.3%
Drug Interaction 4.8%
Histiocytosis Haematophagic 4.8%
Thrombocytopenia 4.8%
White Blood Cell Count Decreased 4.8%
Acute Febrile Neutrophilic Dermatosis 4.2%
Pancreatitis 3.9%
Pancreatitis Acute 3.7%
Squamous Cell Carcinoma 3.7%
Leukopenia 3.4%
Pneumonia 3.1%
Tachycardia 3.1%
Drug Exposure During Pregnancy 2.8%
Hepatitis 2.8%
Nausea 2.8%
Rash 2.8%
Secondary
Crohn's Disease 21.6%
Immunosuppression 12.9%
Product Used For Unknown Indication 10.8%
Renal Transplant 9.6%
Colitis Ulcerative 7.6%
Drug Use For Unknown Indication 6.5%
Rheumatoid Arthritis 4.5%
Systemic Lupus Erythematosus 4.4%
Lung Transplant 3.3%
Heart Transplant 2.3%
Lupus Nephritis 2.2%
Psoriasis 2.0%
Organ Transplant 2.0%
Pemphigus 1.8%
Immunosuppressant Drug Therapy 1.8%
Prophylaxis Against Transplant Rejection 1.7%
Liver Transplant 1.4%
Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis 1.3%
Wegener's Granulomatosis 1.2%
Vasculitis 1.2%
Basal Cell Carcinoma 13.2%
Weight Decreased 7.0%
Vomiting 6.7%
Pancytopenia 6.4%
Thrombocytopenia 6.4%
Pyrexia 6.1%
Sepsis 6.1%
Pneumonia 5.0%
Leukopenia 4.8%
Progressive Multifocal Leukoencephalopathy 4.4%
Hepatosplenic T-cell Lymphoma 4.3%
Squamous Cell Carcinoma 4.0%
Neck Pain 3.7%
Respiratory Failure 3.5%
Systemic Lupus Erythematosus 3.4%
Renal Failure 3.1%
White Blood Cell Count Decreased 3.1%
Tuberculosis 3.0%
Urosepsis 3.0%
Transplant Rejection 2.9%
Concomitant
Crohn's Disease 33.1%
Product Used For Unknown Indication 20.6%
Drug Use For Unknown Indication 11.2%
Colitis Ulcerative 6.5%
Rheumatoid Arthritis 6.3%
Renal Transplant 3.3%
Hypertension 2.5%
Immunosuppression 1.9%
Prophylaxis 1.8%
Pain 1.7%
Systemic Lupus Erythematosus 1.4%
Depression 1.2%
Osteoporosis 1.2%
Inflammatory Bowel Disease 1.2%
Premedication 1.1%
Idiopathic Thrombocytopenic Purpura 1.0%
Immunosuppressant Drug Therapy 1.0%
Prophylaxis Against Transplant Rejection 1.0%
Vitamin Supplementation 0.9%
Heart Transplant 0.9%
Crohn's Disease 14.9%
Vomiting 9.4%
Weight Decreased 9.3%
Pyrexia 9.1%
Injection Site Pain 6.4%
Sepsis 5.1%
Urinary Tract Infection 5.0%
Drug Ineffective 4.3%
Pain 4.0%
Pneumonia 3.7%
Colitis Ulcerative 3.4%
Weight Increased 3.2%
Renal Failure 3.0%
Intestinal Obstruction 2.9%
Tremor 2.9%
Incorrect Dose Administered 2.7%
Pain In Extremity 2.7%
Death 2.6%
Urticaria 2.6%
Tachycardia 2.6%
Interacting
Crohn's Disease 19.4%
Immunosuppression 8.8%
Colitis Ulcerative 8.2%
Rheumatoid Arthritis 7.1%
Product Used For Unknown Indication 6.5%
Pulmonary Tuberculosis 6.5%
Drug Use For Unknown Indication 4.7%
Renal Transplant 4.7%
Hypertension 4.1%
Muscular Weakness 3.5%
Systemic Lupus Erythematosus 3.5%
Takayasu's Arteritis 3.5%
Immunosuppressant Drug Therapy 2.9%
Pneumonia 2.9%
Prostate Cancer 2.9%
Diabetes Mellitus 2.4%
Iridocyclitis 2.4%
Liver Transplant 2.4%
Obliterative Bronchiolitis 1.8%
Osteoporosis 1.8%
Drug Interaction 38.3%
Thrombocytopenia 10.6%
Haemolytic Uraemic Syndrome 6.4%
Aplasia Pure Red Cell 4.3%
Hodgkin's Disease Nodular Sclerosis Stage Unspecified 4.3%
Pancytopenia 4.3%
Ventricular Extrasystoles 4.3%
Alanine Aminotransferase Increased 2.1%
Blood Bilirubin Increased 2.1%
Depressed Level Of Consciousness 2.1%
Eye Swelling 2.1%
Hepatic Encephalopathy 2.1%
Hepatocellular Injury 2.1%
Immunosuppressant Drug Level Decreased 2.1%
Infected Bites 2.1%
Influenza 2.1%
Metastases To Peritoneum 2.1%
Myalgia 2.1%
Pain 2.1%
Polymyositis 2.1%